Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Predictive Gene Expression Profile of Sunitinib Rate Response in Metastatic Clear Cell Renal Carcinomas

NCT04415697 is registered in ClinicalTrials.gov with Barretos Cancer Hospital as lead sponsor.

NCT NCT04415697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04415697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Predictive Gene Expression Profile of Sunitinib Rate Response in Metastatic Clear Cell Renal Carcinomas
Lead sponsor
Barretos Cancer Hospital
Phase
Observational
Overall status
Completed
Start date
January 2, 2019
Completion date
April 10, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, gene expression, kidney cancer